OMER News and Press, Omeros Corporation From 10/18/21

Gainers: Valneva SE VALN +33%, MeiraGTx (NASDAQ:MGTX) +22%, Adamis Pharmaceuticals ADMP +20%, Aerovate Therapeutics AVTE +18%, Progenity (NASDAQ:PROG) +16%. Losers: Revance Therapeutics RVNC -42%, Omeros OMER -25%, MannKind MNKD...

Earnings news provided a key theme for Monday's pre-market trading. Philips (NYSE:PHG) fell in response to its quarterly report, while better-than-expected results sparked an advance in Albertsons (NYSE:ACI). In other news, Zillow (NASDAQ:Z) dropped in pre-market action after pausing its home...

Revance Therapeutics (NASDAQ:RVNC) -33% after FDA declines to approve wrinkle injection. MannKind (NASDAQ:MNKD) -18% as FDA declines to approve United Therapeutics’ heart disease drug Omeros (NASDAQ:OMER) -17% after FDA fails to approve narsoplimab treatme...

-- Conference call today at 8:30 a.m. ET, 5:30 a.m. PT -- Omeros Corporation (Nasdaq: OMER) today announced that the company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for narso...

Halloween goblins came early for Omeros shareholders with its 10/2021 "deficiency" announcement. Omeros' financial condition is fraught with daunting prospects of near-term dilution. Omeros' pipeline is front and center for the near future, with OMIDRIA playing a critical role. ...

Deal speculation involving Ford (NYSE:F) and Tata Motors (NYSE:TTM) sparked buying interest in Friday's midday trading. The companies are reportedly working on a deal for Ford's India operations. Take-Two Interactive (NASDAQ:TTWO) was another high-profile name garnering attention in intraday ...

Gainers: ChemoCentryx CCXI +57%, ReShape Lifesciences (NASDAQ:RSLS) +30%, Voyager Therapeutics VYGR +13%, Sundial Growers (NASDAQ:SNDL) +10%, Flora Growth (NASDAQ:FLGC) +6%. Losers: Allogene Therapeutics ALLO -42%, Cellectis CLLS -19%,&#x...

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Omeros Corporation (“Omeros” or the “Company”) (NASDAQ: OMER) on behalf of Omeros stockholders. Our investigation concerns whether ...

Gainers: Xenon Pharmaceuticals XENE +76%, Milestone Scientific (NYSE:MLSS) +15%, Clene (NASDAQ:CLNN) +12%, OpGen OPGN +11%, Adverum Biotechnologies ADVM +8%. Losers: Owlet (NYSE:OWLT) -25, REGENXBIO (NASDAQ:RGNX) -21%, Omeros (NASDAQ...

Welcome to the "Merck Cures COVID!" edition of Hot Stocks. Of course, the drug maker didn't actually cure the disease. But it did release blockbuster clinical-trial data for an anti-COVID pill that contributed to an overall Wall Street rally. Many segments of the market took the MRK anno...